Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 46 AL 60

[Pharmacotherapy and dementia]

Drobizhev MY, Fedotova AV, Kikta SV, Antokhin EY.

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(10):110-116. doi: 10.17116/jnevro2016116101110-116.

[Preventive effects of curcumin and resveratrol in Alzheimer’s disease]

Tęcza P, Żylińska L.

Przegl Lek. 2016;73(5):320-3.

Medicinal Chemistry Focusing on Aggregation of Amyloid-β

Sohma Y.

Chem Pharm Bull (Tokyo). 2016;64(1):1-7. doi: 10.1248/cpb.c15-00742.

Relearning of Activities of Daily Living: A Comparison of the Effectiveness of Three Learning Methods in Patients with Dementia of the Alzheimer Type

Bourgeois J, Laye M, Lemaire J, Leone E, Deudon A, Darmon N, Giaume C, Lafont V, Brinck-Jensen S, Dechamps A, König A, Robert P.

J Nutr Health Aging. 2016 Jan;20(1):48-55. doi: 10.1007/s12603-016-0675-4.

Tau Biology and Tau-Directed Therapies for Alzheimer's Disease

Bakota L, Brandt R.

Drugs. 2016 Mar;76(3):301-13. doi: 10.1007/s40265-015-0529-0.

Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease

Mattsson N, Schott JM, Hardy J, Turner MR, Zetterberg H.

J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):1000-4. doi: 10.1136/jnnp-2015-311321. Epub 2016 Jan 8.

Editorial: Oxidative Stress and Alzheimer Disease: Where Do We Stand?

Barone E.

Curr Alzheimer Res. 2016;13(2):108-11. doi: 10.2174/156720501302160101123849.

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies

Šimić G, Babić Leko M, Wray S, Harrington C, Delalle I, Jovanov-Milošević N, Bažadona D, Buée L, de Silva R, Di Giovanni G, Wischik C, Hof PR.

Biomolecules. 2016 Jan 6;6(1):6. doi: 10.3390/biom6010006.

Nuclear Tau and Its Potential Role in Alzheimer's Disease

Bukar Maina M, Al-Hilaly YK, Serpell LC.

Biomolecules. 2016 Jan 7;6(1):9. doi: 10.3390/biom6010009.

Epileptic Seizures in Alzheimer Disease: A Review

Horváth A, Szűcs A, Barcs G, Noebels JL, Kamondi A.

Alzheimer Dis Assoc Disord. 2016 Apr-Jun;30(2):186-92. doi: 10.1097/WAD.0000000000000134.

Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?

Roher AE, Maarouf CL, Kokjohn TA.

J Alzheimers Dis. 2016;50(3):645-58. doi: 10.3233/JAD-150757.

Comparison of the Psychometric Properties of the "Word" and "Picture" Versions of the Free and Cued Selective Reminding Test in a Spanish-Speaking Cohort of Patients with Mild Alzheimer's Disease and Cognitively Healthy Controls

Delgado C, Muñoz-Neira C, Soto A, Martínez M, Henríquez F, Flores P, Slachevsky A.

Arch Clin Neuropsychol. 2016 Mar;31(2):165-75. doi: 10.1093/arclin/acv107. Epub 2016 Jan 11.

The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer's disease: Acting separately or synergistically?

Song C, Shieh CH, Wu YS, Kalueff A, Gaikwad S, Su KP.

Prog Lipid Res. 2016 Apr;62:41-54. doi: 10.1016/j.plipres.2015.12.003. Epub 2016 Jan 4.

Potential of monitoring isotopologues by quantitative gas chromatography with time-of-flight mass spectrometry for metabolomic assay

Wang Y, Hu H, Su Y, Zhang F, Guo Y.

J Sep Sci. 2016 Mar;39(6):1137-43. doi: 10.1002/jssc.201501137. Epub 2016 Feb 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias